mRNA-1195 clinical trials

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

This study is looking into a new medicine called mRNA-1195 to see if it can help stop relapses in people with Multiple Sclerosis (MS). It compares mRNA-1195 with a dummy treatment (placebo) to check its safety and how the body reacts to it.